Treatment of Progressing stroke. Stroke 12: 397^109, 1981 13. Whisnant JP: Discussion in Ref. (3) cranial artery abnormalities, e.g. the internal carotid, M, portions of middle cerebral, the vertebral, the basilar, and proximal portions of the posterior cerebral arteries. The severe stenotic group which showed 75 per cent or more constriction in some of these major cranial arteries consisted of 25 patients (19 males, 6 females, mean age 50 years). The remaining 23 patients (15 males, 8 females, mean age 58 years) were included in the less stenotic group: their angiograms showed moderate constriction (less than 75 per cent) or no stenosis.
Angiographic examination were usually performed by the direct puncture method and selection of appropriate vessels was based upon clinical symptoms, e.g. a left carotid angiogram was performed for a right hemiparesis. Complete four vessels study was undertaken in only a few patients. Diabetes mellitus was found in three patients, 2 in the severe stenotic and one in the less stenotic group. All hypertensive patients in the less stenotic group received antihypertensive medication. Despite this, labile hypertension persisted in half of the patients and the remaining half were highly resistant to therapy. The majority of the severe stenotic group were almost normotensive and required no therapy for hypertension after their stroke.
Platelet aggregation was examined by Born's turbidometric method, in the post-acute period of cerebral thrombosis (more than two weeks after onset). No subject was taking drugs known to affect platelet function within 7 days prior to examination. the persistence of hypertension was significantly increased in the less stenotic group (table 2) .
Platelet aggregation study in the hypertensive nonstroke control group is compared with those of the hypertensive stroke patients (table 3) . Hypertensive stroke patients with less stenosis showed significantly enhanced platelet aggregation from the control subjects (p < 0.05).
Discussion
A number of workers have studied the significance of platelet aggregation in cerebral ischemic diseases. Much of the evidence is, however, conflicting. Sano et al., 1 found that platelet aggregation in both myocardial and cerebral infarction was increased in the acute period, but no differences existed in the chronic phase. Dougherty et al., 2 showed similar results in patients with transient ischemic attacks (TIA) and cerebral thrombosis, whereas Danta 3 showed enhanced platelet aggregation in the post acute phase of stroke. A likewise enhanced aggregation in the chronic phase was reported by Couch et al. , 4 but they noticed a statistically significant difference from the control only in the age group under 60 years. Different methods used by these workers are at least partly responsible for the varied results, but underlying etiologic factors may be more important. We feel that patients with cerebral thrombosis comprise a heterogeneous group that can be subdivided. Each group has distinct etiologies, and platelet aggregation within the groups also differ. Our study was undertaken to show if any evidence exists for such a theory. We chose to examine platelet aggregation in the post-acute phase of cerebral thrombosis (more than two weeks after onset). Since platelet aggregation in the acute phase may be affected by stress associated with the disease process itself, an examination of measurements of platelet aggregation in the post-acute phase of stroke is therefore more representative of a risk factor. The patients with cerebral thrombosis were divided into two groups (severe stenotic and less stenotic group). We expected that this division might reveal an etiological difference. The majority of the less stenotic group had persistent hypertension and small infarctions in the deep structures of the cerebrum such as basal ganglia. This indicates the relative homogeneity in etiology of this group. In the severe stenotic group, although many had previous history of hypertension, relatively few patients required ongoing antihypertensive medication. Anatomically, three patterns of infarction were found by CT, that is, both cortical and deep involvement, and cortical or deep involvement alone. These data suggest that the severe stenotic group is not such a homogeneous group and has more complex risk factors (increased blood viscosity due to hemoconcentration, decreased perfusion pressure caused by hypotension, congenital anomaly of vessels, etc. 5 Platelet aggregation was statistically increased in the less stenotic group (p < 0.05).
Among many reports of platelet aggregation in cerebral ischemia, only Andersen et al. 6 examined the correlation between aggregation and angiographic findings. Their study of patients with TIA showed tAbout half of the patients showed labile hypertension and half were highly resistant to antihypertensive therapy. enhanced aggregation in 7 of 10 angiographically normal patients, whereas enhanced aggregation was present in 5 of 14 with abnormal angiograms. There was no statistical correlation. However, a higher incidence of enhanced aggregation in angiographically normal patients (70%) is still noteworthy.
Al-Mefety et al. 7 reported platelet hyperfunction (increased adhesiveness and aggregation) in 22 patients with TIA who had no evidence of atherosclerosis. Aspirin and sulfinpyrazone were effective in preventing TIA's in these patients. They suggested that a group of patients with TIA's exists in whom the sole cause of the attack is an abnormality of platelet function. The less stenotic group in our study may correspond to Al-Mefety's specific group of TIA patients. An important question remains to be answered. Is enhanced platelet aggregation in the less stenotic group a true risk factor for cerebral thrombosis? In order to reply it is necessary to study a control group matched for the same degree of vessel stenosis, age and sex. We selected a group of non-stroke hypertensive subjects. Platelet aggregation in hypertensive stroke patients in the less stenotic group was significantly increased from those of hypertensive control subjects without stroke. From these observations, it is suggested that a combination of enhanced platelet aggregation and hypertension increases the risk of a specific type of infarction characterized by mild stenotic changes of major cranial arteries and small infarction in the deep structures of the brain. Acknowledgment
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THE RELATIONSHIP BETWEEN ELECTROCAR-DIOGRAPHIC CHANGES associated with subarachnoid hemorrhage (SAH) has been documented since 1947 when Byer et al. 1 described large upright T-waves and prolonged Q-T intervals in a patient with subarachnoid hemorrhage that occurred secondary to a ruptured aneurysm. Since that time reports have appeared that suggest an association between SAH and electrocardiographic abnormalities 2 " 5 although the realization regarding the life threatening nature of these cardiac arrhythmias is a fairly recent one. 5 Moreover, when there is a concomitant impairment of consciousness and no clinical history, the disturbances of the cardiac rhythm may appear to be the primary illness of these patients. 6 In order to be able to study the electrocardiographic changes occurring secondary to a sudden SAH and the mechanisms involved in producing these changes, an SUMMARY The male Sprague-Dawley rat was successfully used to produce increases in arterial blood pressure and electrocardiographic abnormalities similar to those seen in patients after a subarachnoid hemorrhage. The model employs a less expensive, easily available laboratory animal than other existing models. Whole heparinized blood is introduced in the area of the circle of Willis to simulate a subarachnoid hemorrhage. This model ensures a constant body-blood volume and minimizes damage to brain tissue as no blood vessel has to be punctured. The volume of blood required to produce bradycardia and other electrocardiographic abnormalities can be controlled and calculated for each animal. The model produced a sudden onset and progression of cardiovascular symptoms. Blood apparently is specific for producing electrocardiographic abnormalities as compared to 0.9% saline, Dextran 40 and Gentran 75 when introduced in the area of the circle of Willis. This specificity was not maintained when blood and saline were introduced into the cisterna magna as electrocardiographic abnormalities were observed with both agents.
Stroke, Vol 14, No 3, 1983 
